Re: ~*Online WACOC News 2007 September 19*~

On Nov 4, 4:13�am, DGSaba <dgs...@xxxxxxx> wrote:
On Nov 3, 1:04 pm, DGSaba <dgs...@xxxxxxx> wrote:





Women and Children of CFIDS + Men
WACOC + M

~*A comment or two*~

Happy Autumn! Hope everyone had a great halloween this year!

Welcome to all new readers and to those just catching up...

For those with Fibromyalgia be sure to go :
back to 1989 and read the following...

Title: Fibromyalgia and its relation to chronic fatigue syndrome,
viral illness and immune abnormalities
Author: Goldenberg DL

Fibromyalgia and chronic fatigue syndrome have similar clinical and
demographic features. We found that most patients with chronic
fatigue syndrome have a tender point examination similar to patients
with fibromyalgia. Similar pathophysiologic mechanisms are also being
explored in each syndrome, including potential role for viral induced
immune dysfunction.

To read the entire article go to:
National Library of Medicenehttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed

Also, research United States Patent Number: 5,242,820 Lo Date of
Patent: Sep 7, 1993
Pathogenic Mycoplasma
Inventor Shyh-Ching Lo, Potomac Md.
National Library of Medicene
Title: Mycoplasmas and oncogenesis: persistent infection and
mulitstage malignant transformation
Author: TsaiS; Wear DJ; ShihJW; Lo SC
American Registry of Pathology, Department of Infectious and Parasitic
Disease Pathology, Armed Forces Institute of Pathology,, Washington DC
20306-6000, USA.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed

Patent Number 5,604,093 Salahuddin et al Date of Patent: Feb 18,1997
Human Herpesviurs-6 (HHV-6)Isolution and Products

Now then, go to: The Institute for Molecular Medicinehttp://www.immed.org/

Also, read:
Genomic Polymorphism, Growth Properties, and Immunologic Variations in
Juman Herpersvirus-6 Isolates

D.V. Ablashi, N. Balachandran, S.F. Josephs, C.L. Hung, G. R. F.
Krueger, B. Kramarskt, S.Z. Salahuddin and R. C. Gallo

Laboratory of Cellular and Molecular Biology, National Cancer
Institute, Bethesda, Maryland, 20892;
Department of Microbiology, Molecular Genetics and Immunology,
University of Kansas Medical Center, Kansas City, 66103; Laboratory of
Tumor Cell Biology, National Cancer Institute, Bethesda, Maryland
20892; Pharmacia Diagnostics, Inc, Silver Spring, Maryland,
20904-1912; Institute of Pathology, University of Koin, Loin West
Germany; and School of Medicine, University of Southern California,
Los Angeles, California 90003

Last but not least see:

New Diagnostic Tool for Chronic Fatigue Syndrome (CFS) Presented to
Annual Meeting of American College of Allergy, Asthma and Immunology

CHICAGO, IL, Nov. 12, 1999, New data presented to the Annual Meeting
of the American College of Allergy, Asthma and Immunology suggests the
discovery of a potential diagnostic tool and therapeutic measurement
for CFS.
The Centers for Disease Control and Prevention, report that chronic
fatigue symptoms affect more than 14 million people between the ages
of 17-69 and in twice as many women as men. "Currently, the diagnosis
of CFS involves a lengthy procedure of eliminating other possible
causes of severe fatigue lasting more than six consecutive months,"
said Dr. Joseph Bellanti, M.D., and Director of the International
Center for Interdisciplinary Studies of Immunology at Georgetown
University Medical Center, who identified a simple-to-test for urinary
marker in CFS patients.

The rest of this article can be read at:http://www.enadh.com/press.html

The CDC in 1999 were quoting more than 14 million...
Here it is 2007 and what are the numbers now?
Lastest news was over 1 million, and then we heard 4 million but if it
was 14 million back in 1999 how could this be? Why can't the CDC get
their numbers together?

Thanks again, Quintero, for all the information and also thanks to
Shirley Bentley, President of U.S. Chapter Common Cause Medical
Research Foundation, Rochester, NY 14612 USA

Congratulations to The National CFIDS Foundation (NCF) on their 10th
Year Anniversary 2007!
Please read the latest research and medical discoveries concerning
neurotoxins and more!http://www.ncf-net.org/Discoveries.htm

Soft hugs to all who need them,
Diana Saba
Disabled Retired Nurse
http://hometown.aol.com/dgsaba/myhomepage/index.html

ps...don't forget to set your clocks back :-)

And, to read more regarding mycoplasma...

Google keywords: " Dr Thomas McPherson Brown "http://groups.google.com/groups/search?hl=en&qt_s=1&q=%22+Dr+Thomas+M...

Google keywords: Mycoplasma dgsaba  (250) posts on mycoplasmahttp://groups.google.com/group/alt.med.fibromyalgia/search?hl=en&q=my...

See the following entries on my homepage since 2003http://hometown.aol.com/dgsaba/myhomepage/index.html

According to DR Shyh-Ching Lo, senior researcher at The Armed Forces
Institute of Pathology and one of America's top mycoplasma
researchers, this disease agent causes many illnesses including AIDS,
cancer, chronic fatigue syndrome, Crohn's colitis, Type I diabetes,
multiple sclerosis, Parkinson's disease, Wegener's disease and
collagen-vascular diseases such as rheumatoid arthritis and
Alzheimer's.http://www.mercola.com/2001/sep/8/mycoplasma.htm

Excerpt from Co-Cure:
Optimal Wellness Center article on pathogenic mycoplasma Co-Cure
members may be interested in an article on pathogenic mycoplasma that
is in the September 8th issue of Dr. Joseph Mercola's Optimal Wellness
Centerathttp://www.mercola.com/2001/sep/8/mycoplasma.htm

Dr. Mercola writes, "Mycoplasma used to be very harmless until it was
manipulated during bio-warfare efforts. Now Mycoplasma can take over
cells
and destroy them, this includes cells in the brain as well." The
article is
by Donald W. Scott, MA, MSc of the Common Cause Medical Research
Foundation.

More information on HHV6 is now available, as well, at the following
site:http://hhv6.freeservers.com/

Patent Tidbits
U.S. Patent 5,604,093: Human Herpes virus-6
(HHV-6) Isolution and Products (Chronic Fatigue Syndrome; Health and
Human Services) February 18, 1997

U.S. Patent 5,189,022: underlying viral cause of CFS (Health and Human
Services)

U.S. Patent 5,242,820: Pathogenic Mycoplasma
(Mycoplasma fermentans in CFS; Department of Defense) September 7,
1993

U.S. Patent 5,827,750: JHK Virus in CFIDS
(Grossberg retrovirus)
National Institutes of Health Grant RO1-AI-32710

Why does the United States of America and Department of Defense (DOD)
own these patents?

CFSAC Meeting Presentation ~ June 21, 2004http://listserv.nodak.edu/scripts/wa.exe?A2=ind0407a&L=co-cure&F=&S=&;...

Please keep in mind that *several *times *the *same *information *was
*presented to the CFSCC/CFSAC meetings but *never* *recorded *into
*the *minutes of the meetings transcripts until I *once *again *took
*their *same words back to Washington DC and *presented *them *once
*again June 21, 2004 which has spoken volumes to those investigating
these matters at the CFSCC/CFSAC meetings...

This is only a partial excerpt from the above CFSAC Meeting
Presentation:

On October 13, 1999, a meeting of CFS patient advocates and the CDC
took
place. One of the important research recommendations was to "assess
the risk of
CFS being spread by blood and blood products, and if such a risk is
found,
develop a prevention strategy for protecting the nation's blood
supply."

It appears that the CDC, along with other respected researchers both
in the
U.S. and Europe, have completed some studies on the blood of CFS
patients.
These studies have revealed numerous biological diagnostic markers.

While blood testing has for years documented that a high percentage of
CFS
patients have EBV, CMV, Herpes 6 and mycoplasma in their blood,
transmissibility
of CFS in blood transfusions was finally documented in the DeMeirleir
study.
(see footnotes 1, 2, 3, 4, 5, 6 for specific research and
researchers.)

Using the percentage of 4.5% obtained in the DeMeirleir's research, it
is
reasonable to assume that 45,000 people out of the one million U.S.
CFS patients
may have acquired their disease from the blood supply.

Where is the attempt now to guard the U.S. blood supply and inform the
medical community, the media, and the general public?

Footnotes:
1. CDC study entitled Utility of the blood for gene expression
profiling and
biomarker discovery in chronic fatigue syndrome. Vernon SD, Unger ER,
Dimulescu IM, Rajeevan M, Reeves WC (Disease Markers 18: 193-199,
2002)

A reading of the summary revealed that "Eight genes were
differentially
expressed in both an age-matched case-control analysis and when
comparing all CFS
cases to all controls. Several of the differentially expressed genes
are
associated with immunologic functions (e.g., CMRF35 antigen, IL-8, HD
protein) and
implicate immune dysfunction in the pathophysiology of CFS. These
results
successfully demonstrate the utility of the blood for gene expression
profiling to
distinguish subjects with CFS from healthy controls and for
identifying genes
that could serve as CFS biomarkers.

2. Blood Transfusion and Chronic Fatigue Syndrome, K. De Meirleir, P.
De
Becker, I. Campine, Human Physiology and Medicine, Vrije Universiteit
Brussel,
Brussels, Belgium
. . . . .4.5% percent of a study group of CFS patients developed CFS
within a
week of having a blood transfusion.

3. Red Laboratories whose corporate headquarters is located in
Brussels has
developed a test using the pioneering technology of Dr. Robert
Suhadolnik of
Temple University in the U.S. which shows the presence of an abnormal
protein
in a subset of patients with CFS and other cellular proteins that play
important roles in the pathogenesis of immune dysfunction. This test
is now being
marketed in Europe as a way to reduce the number of transfusion-
related
infections with persistent (and covert) viral infections.

4. Red Laboratories shows presence ...

read more »- Hide quoted text -

- Show quoted text -

ps... ps...I use to work at The Arthritis Institute of the National
Hospital, Arlington Virginia and maybe we should ask the NIH how many
times did Dr. Thomas McPherson Brown apply for NIH Grants and how many
years did they turn him down? Dr. Brown was on to something and he
knew it and so did others including the NIH but time after time he was
turned down, how many times, I don't remember, as its 2007 now and
this was back in the mid 1980's when I worked with his patients. The
last I heard the hospital is no longer even there, its been torn down
and an apartment building was built in its place...

See full article below:

Excerpt:
An Hypothesis. If antibiotic therapy is effective in RA, as is
suggested by these data, the mechanism of action may be similar to
that observed in the treatment of Lyme disease38 with antibiotics or
of Tetracycline in the treatment of bypass arthrltis.39 That is, if
mycoplasmas are an inciting agent in RA, then either or both of the
mechanisms hypothesized by Bennett may be operative: (a) the
mycoplasma may localize within the joint space and trigger an immune
response, and/or (b) the mycoplasma may localize in a distant site and
trigger a systemic immune response which produces synovitis. Either
hypothesis is consistent with the apparent beneficial effects observed
in these 98 study patients.

http://www.rheumatic.org/drbrown.htm

A Legacy of Health
http://www.rheumatic.org/

Enjoy the sunsets and sunrises,

Diana Saba
Retired Nurse
FM ME/CFIDS
Related Neurological Disorders
CDC's Wm Reeves Must Go
Bring Back the GAO
Thanks to the GAO for listening and then investigating!

There is a link to the CDC Off Center report now at:
http://coburn.senate.gov/ffm/index.cfm?FuseAction=OversightAction.Hom...

Which do you believe in -- political science or medical science? :-)



.

Relevant Pages

  • ~*Online WACOC News 2006 November 24*~
    ... -- I understand even more so now why patients and patient advocates who ... On October 13, 1999, a meeting of CFS patient advocates and the CDC ... CFS being spread by blood and blood products, and if such a risk is ... CFSAC Meeting Presentation ~ June 21, ...
    (alt.med.fibromyalgia)
  • Re: ~*Online WACOC News 2007 April 12*~
    ... Potential Animal Virus Identified in Patients with Chronic ... Special attention should be paid to the fact that blood testing has ... The CFSAC should be aware that the majority of the CFS community ... NCF should be fully recognized by the CDC and included as patient ...
    (alt.med.fibromyalgia)
  • Re: ~*Online WACOC News 2007 September 19*~
    ... We found that most patients with chronic ... New Diagnostic Tool for Chronic Fatigue Syndrome (CFS) Presented to ... Mycoplasma dgsaba posts on mycoplasma ... CFS being spread by blood and blood products, and if such a risk is ...
    (alt.med.fibromyalgia)
  • Re: ~*Online WACOC News 2007 September 19*~
    ... We found that most patients with chronic ... New Diagnostic Tool for Chronic Fatigue Syndrome (CFS) Presented to ... Mycoplasma dgsaba posts on mycoplasma ... CFS being spread by blood and blood products, and if such a risk is ...
    (alt.med.fibromyalgia)
  • ~*Online WACOC News 2006 August 19*~
    ... there continues to be mass illness confusion. ... is NOT the same thing as the illness 'CFS' that the ... concept of identifying symptoms that patients have - or don't have. ... corrected QT interval (QTc) in CFS differs from QTc in other ...
    (alt.med.fibromyalgia)
Loading